Abstract 11795: Identification of Celastramycin as a Novel Therapeutic Agent for Pulmonary Arterial Hypertension -High-throughput Screening of 5,562 Compounds-
Circulation(2019)
摘要
Introduction: Pulmonary arterial hypertension (PAH) is characterized by enhanced proliferation of pulmonary artery smooth muscle cells (PASMCs) accompanying increased production of inflammatory fac...
更多查看译文
关键词
celastramycin,pulmonary arterial hypertension,novel therapeutic agent,arterial hypertension,high-throughput
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要